Home/Pipeline/Metabolica 4‑cresol Pharmaceutical

Metabolica 4‑cresol Pharmaceutical

Type 2 Diabetes, Obesity, NAFLD/NASH

PreclinicalActive

Key Facts

Indication
Type 2 Diabetes, Obesity, NAFLD/NASH
Phase
Preclinical
Status
Active
Company

About Metabolica Health

Microbiome‑driven 4‑cresol platform targeting regenerative metabolic disease.

View full company profile